Clinical pharmacist integration into the oncology medical home.

Chan, Mandy Y.; Yu, Andrew Kenneth; Lau, Rebecca W.; Linh, Eva; Chen, Eric; Birmingham, Karen

doi:10.1200/jco.2015.33.15_suppl.e20703

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A conceptualized model of the interactive patient and healthcare professional roles across the course of treatment can foster improved patient-centered care [ 40 ]. Oncology pharmacists are essential for expedition of initial therapy start, subsequent therapeutic management decisions, foreseeable prevention of adverse effects, and ongoing provision of high quality, patient centered and evidence based care [ 44 , 47 , 67 , 68 ]. Integration of oncology pharmacists into the cancer care team and healthcare model is vital for effective delivery of care for patients [ 69 ].…”

Section: Patients As Cancer-care Providersmentioning

confidence: 99%

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations

et al. 2018

View full text Add to dashboard Cite

Interprofessional care is exhibited in outpatient oncology practices where practitioners from a myriad of specialties (e.g., oncology, nursing, pharmacy, health informatics and others) work collectively with patients to enhance therapeutic outcomes and minimize adverse effects. Historically, most ambulatory-based anticancer medication therapies have been administrated in infusion clinics or physician offices. Oral anticancer medications (OAMs) have become increasingly prevalent and preferred by patients for use in residential or other non-clinic settings. Self-administration of OAMs represents a significant shift in the management of cancer care and role responsibilities for patients and clinicians. While patients have a greater sense of empowerment and convenience when taking OAMs, adherence is a greater challenge than with intravenous therapies. This paper proposes use of a qualitative systems evaluation, based on theoretical frameworks for interdisciplinary team collaboration and systems science, to examine the social interactionism involved with the use of intravenous anticancer treatments and OAMs (as treatment technologies) by describing patient, organizational, and social systems considerations in communication, care, control, and context (i.e., Kaplan’s 4Cs). This conceptualization can help the healthcare system prepare for substantial workforce changes in cancer management, including increased utilization of oncology pharmacists.

show abstract